Equity Profile

RVTY

Revvity, Inc.

Health CareLife Sciences Tools & Services$11.7B

Jul27Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies that support research and development in the medical field....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors to gauge financial health.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and is critical for assessing future performance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies that support research and development in the medical field. With a market cap of $12 billion, Revvity plays a crucial role in advancing healthcare solutions, particularly as the industry increasingly relies on innovative technologies to improve patient outcomes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1-2026, Revvity reported an EPS of $1.04, slightly beating estimates and resulting in a 6.69% increase in stock price the following day. However, revenue figures were not disclosed, leaving some uncertainty about overall performance.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Revvity's upcoming earnings, especially given its strong track record of beating EPS estimates. However, the lack of revenue guidance raises concerns about future growth.

Bull Case

If Revvity continues its trend of beating EPS estimates and provides positive revenue guidance, it could lead to a significant stock price increase, reflecting strong investor confidence.

Bear Case

Conversely, if the company fails to meet expectations or provides disappointing guidance, it could lead to a decline in stock price, especially given the high implied volatility in the options market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q2-2026, and how does it compare to previous quarters?

Given Revvity's history of beating EPS estimates, this figure will be critical in determining investor sentiment and stock performance.

Will Revvity provide any revenue guidance for the upcoming quarters?

Revenue guidance is essential for assessing the company's growth trajectory and could significantly impact stock price.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to sustain its earnings growth despite the lack of revenue guidance, as historical performance shows a consistent ability to beat EPS estimates.

Supporting Evidence

Revvity has a 100% EPS beat rate over the last eight quarters, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting that investors are anticipating significant news.

Insider selling activity may indicate a lack of confidence in the stock's near-term performance, contrasting with the overall bullish sentiment.

Key Risk

If the EPS comes in below $1.00, it could significantly shift investor sentiment and validate bearish concerns.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Revvity's ability to maintain its earnings momentum and provide clarity on future revenue growth.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move of approximately 5.73%, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$7,424.00

80 sh

1 insider

Net

$7,424.00

Net selling

Most Active Insiders· 1 open-market trade

Vice President and CAOGonzales Anita
$7,424.00
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations and raises guidance, history suggests a potential stock increase of around 0.94% on the following day.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may experience muted movement as investors reassess their outlook.

Miss

If the company misses expectations, history suggests a potential decline of around 0.94%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth expectations for the upcoming quarters.
2Details on cost management strategies and their impact on gross margins.
3Insights into market trends and how Revvity plans to capitalize on them.
4Any commentary on competitive pressures in the life sciences tools and services sector.
5Management's outlook on future product developments and innovations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aon plc

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services, providing essential technologies that support research and development in the medical field....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors to gauge financial health.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and is critical for assessing future performance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Revvity continues its trend of beating EPS estimates and provides positive revenue guidance, it could lead to a significant stock price increase, reflecting strong investor confidence.

Bear Case

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported EPS for Q2-2026, and how does it compare to previous quarters?

Given Revvity's history of beating EPS estimates, this figure will be critical in determining investor sentiment and stock performance.

Will Revvity provide any revenue guidance for the upcoming quarters?

Revenue guidance is essential for assessing the company's growth trajectory and could significantly impact stock price.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to sustain its earnings growth despite the lack of revenue guidance, as historical performance shows a consistent ability to beat EPS estimates.

Supporting Evidence

Revvity has a 100% EPS beat rate over the last eight quarters, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting that investors are anticipating significant news.

Insider selling activity may indicate a lack of confidence in the stock's near-term performance, contrasting with the overall bullish sentiment.

Key Risk

If the EPS comes in below $1.00, it could significantly shift investor sentiment and validate bearish concerns.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Revvity's ability to maintain its earnings momentum and provide clarity on future revenue growth.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bull case, indicating continued strong performance.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case, raising concerns about profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move of approximately 5.73%, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$7,424.00

80 sh

1 insider

Net

$7,424.00

Net selling

Most Active Insiders· 1 open-market trade

Vice President and CAOGonzales Anita
$7,424.00
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations and raises guidance, history suggests a potential stock increase of around 0.94% on the following day.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may experience muted movement as investors reassess their outlook.

Miss

If the company misses expectations, history suggests a potential decline of around 0.94%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth expectations for the upcoming quarters.
2Details on cost management strategies and their impact on gross margins.
3Insights into market trends and how Revvity plans to capitalize on them.
4Any commentary on competitive pressures in the life sciences tools and services sector.
5Management's outlook on future product developments and innovations.